---
input_text: "Effect of chelation therapy in pediatric Wilson's disease: Liver and
  endoscopic outcome.BACKGROUND: As there is paucity of exclusive literature on pediatric
  hepatic Wilson's disease (WD), this study was undertaken to evaluate the efficacy
  of chelation on hepatocellular function and portal hypertension in WD. METHODS:
  Wilson's disease patients with >=9 months of follow-up were evaluated for response
  to chelation therapy in the following categories: (a) complete remission, (b) partial
  remission (c) progression of disease; (d) drug toxicity. Pediatric end-stage liver
  disease (PELD), Nazar and New Wilson Index scores were compared. Hemodynamically
  stable patients underwent esophagogastroduodenoscopy (baseline and surveillance)
  and received prophylaxis (primary or secondary). Endoscopic outcome was assessed
  at follow-up. RESULTS: Of the 111 WD children (aged 9 [3-15] years; PELD score 16
  [-11 to 60]), 65 with follow-up of 3.6 (0.8-12) years on chelation (83% D-penicillamine
  monotherapy, 17% D-penicillamine and zinc) were analyzed. 81% had severe disease
  at presentation. Favorable outcome (complete and or partial remission), progression
  of disease and drug toxicity were seen in 71%, 29% and 10.8%, respectively. Two-thirds
  had esophageal varices which did not show progression. Large esophageal varices
  (16%) were effectively downgraded in 3 (2-6) therapeutic endoscopic sessions. Nazar
  score and PELD score at baseline were independent predictors of outcome with favorable
  correlation with each other (r = .864, P < .001). PELD cutoff 9.45 (AUC: 71%, sensitivity:
  87%, specificity: 50%; P = .009) and Nazar score cut off 3.5 (AUC: 68%, sensitivity:
  83%, specificity: 50%; P = .02) were associated with poor prognosis. CONCLUSIONS:
  Despite severe liver disease, the majority of hepatic WD can be managed on D-penicillamine
  monotherapy. PELD score and Nazar score effectively determine the outcome."
raw_completion_output: |-
  primary_disease: Wilson's disease

  medical_actions: chelation therapy; D-penicillamine monotherapy; D-penicillamine and zinc treatment; esophagogastroduodenoscopy; therapeutic endoscopic sessions; prophylaxis

  symptoms: hepatocellular dysfunction; portal hypertension; esophageal varices; severe liver disease

  chemicals: D-penicillamine; zinc

  action_annotation_relationships: chelation therapy TREATS hepatocellular dysfunction IN Wilson's disease; chelation therapy TREATS portal hypertension IN Wilson's disease; D-penicillamine monotherapy TREATS severe liver disease IN Wilson's disease; D-penicillamine and zinc treatment TREATS severe liver disease IN Wilson's disease; esophagogastroduodenoscopy PREVENTS complications IN Wilson's disease; therapeutic endoscopic sessions TREATS esophageal varices IN Wilson's disease; prophylaxis PREVENTS complications IN Wilson's disease
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  prophylaxis PREVENTS complications IN Wilson's disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - chelation therapy
    - D-penicillamine monotherapy
    - D-penicillamine and zinc treatment
    - MAXO:0001193
    - therapeutic endoscopic sessions
    - prophylaxis
  symptoms:
    - hepatocellular dysfunction
    - HP:0001409
    - HP:0002040
    - severe liver disease
  chemicals:
    - CHEBI:7959
    - CHEBI:27363
  action_annotation_relationships:
    - subject: chelation therapy
      predicate: TREATS
      object: hepatocellular dysfunction
      qualifier: MONDO:0010200
      subject_extension: chelation
    - subject: chelation therapy
      predicate: TREATS
      object: HP:0001409
      qualifier: MONDO:0010200
    - subject: monotherapy
      predicate: TREATS
      object: HP:0001392
      qualifier: MONDO:0010200
      object_qualifier: severe
      subject_extension: CHEBI:7959
      object_extension: severe
    - subject: treatment
      predicate: TREATS
      object: severe liver disease
      qualifier: MONDO:0010200
      object_qualifier: severe
      subject_extension: D-penicillamine and zinc
    - subject: MAXO:0001193
      predicate: PREVENTS
      object: complications
      qualifier: MONDO:0010200
    - subject: therapeutic endoscopic sessions
      predicate: TREATS
      object: HP:0002040
      qualifier: MONDO:0010200
    - subject: prophylaxis
      predicate: PREVENTS
      object: complications
      qualifier: MONDO:0010200
named_entities:
  - id: MONDO:0009835
    label: Subacute sclerosing panencephalitis
  - id: MONDO:0010200
    label: Wilson disease
  - id: HP:0100785
    label: insomnia
  - id: HP:0001262
    label: excessive daytime sleepiness (EDS)
  - id: HP:0010535
    label: sleep-disordered breathing (SDB)
  - id: HP:0012452
    label: restless legs syndrome (RLS)
  - id: HP:0100580
    label: cataplexy-like episodes (CLEs)
  - id: HP:0025233
    label: sleep paralysis
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0005154
    label: Liver Disease
  - id: HP:0008282
    label: Indirect hyperbilirubinemia
  - id: HP:0002088
    label: Lung disease
  - id: HP:0001396
    label: Cholestasis
  - id: HP:0010836
    label: Abnormal copper levels
  - id: CHEBI:34936
    label: D-penicillamine (DPA)
  - id: CHEBI:888
    label: Dimercaptopropane Sulfonate (DMPS)
  - id: CHEBI:63623
    label: Dimercaptosuccinic Acid (DMSA)
  - id: HP:0000989
    label: itchy skin
  - id: CHEBI:7959
    label: d-penicillamine
  - id: MAXO:0001298
    label: therapy
  - id: HP:0000819
    label: diabetes
  - id: CHEBI:145810
    label: insulin
  - id: CHEBI:28694
    label: copper
  - id: HP:0005268
    label: spontaneous abortions
  - id: MONDO:0016264
    label: Autoimmune Hepatitis (AIH)
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0001394
    label: Cirrhosis
  - id: HP:0006554
    label: acute liver failure
  - id: MONDO:0018982
    label: Niemann-Pick disease type C (NPC)
  - id: HP:0002878
    label: acute respiratory failure
  - id: HP:0001919
    label: acute renal failure
  - id: HP:0200032
    label: Kayser-Fleischer ring
  - id: MAXO:0009004
    label: Exome sequencing
  - id: MONDO:0100288
    label: Enhanced S-cone syndrome
  - id: MONDO:0012669
    label: Legius syndrome
  - id: HP:0002615
    label: Hypotension
  - id: HP:0001649
    label: Tachycardia
  - id: MAXO:0009095
    label: treatment with zinc
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0001001
    label: gene therapy
  - id: CHEBI:50868
    label: penicillamine
  - id: CHEBI:27363
    label: zinc
  - id: HP:0002063
    label: rigidity
  - id: HP:0001260
    label: dysarthria
  - id: HP:0002307
    label: drooling
  - id: CHEBI:16796
    label: Melatonin
  - id: CHEBI:16737
    label: creatinine
  - id: MONDO:0010421
    label: X-linked agammaglobulinemia
  - id: HP:0002204
    label: Pulmonary embolism
  - id: HP:0100806
    label: Sepsis
  - id: HP:0002107
    label: pneumothorax
  - id: HP:0025322
    label: veno-occlusive disease
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: MAXO:0000127
    label: genetic testing
  - id: CHEBI:27899
    label: cisplatin
  - id: HP:0007366
    label: brainstem atrophy
  - id: HP:0012444
    label: brain atrophy
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0002716
    label: Lymphadenopathy
  - id: HP:0001395
    label: liver fibrosis
  - id: CHEBI:39501
    label: triethylenetetramine
  - id: MAXO:0009016
    label: Botulinum toxin type A injection
  - id: CHEBI:3160
    label: Botulinum toxin type A
  - id: MAXO:0001193
    label: upper endoscopy
  - id: CHEBI:62984
    label: zinc acetate
  - id: MONDO:0100192
    label: Liver failure
  - id: HP:0001342
    label: intracerebral hemorrhage
  - id: HP:0000952
    label: Jaundice
  - id: HP:0003256
    label: Coagulopathy
  - id: HP:0001541
    label: Ascites
  - id: HP:0002480
    label: Hepatic encephalopathy
  - id: MONDO:0013209
    label: NAFLD
  - id: MAXO:0000376
    label: Liver biopsy
  - id: HP:0001397
    label: Hepatic steatosis
  - id: HP:0100543
    label: cognitive impairment
  - id: HP:0000713
    label: agitation
  - id: HP:0000737
    label: irritability
  - id: HP:0000739
    label: anxiety
  - id: HP:0000716
    label: depression
  - id: HP:0000741
    label: apathy
  - id: HP:0000746
    label: delusions
  - id: HP:0000738
    label: hallucination
  - id: CHEBI:29987
    label: glutamate
  - id: HP:0004324
    label: weight gain
  - id: CHEBI:16610
    label: spermidine
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:15351
    label: AcCoA
  - id: HP:0001298
    label: Encephalopathy
  - id: MONDO:0005071
    label: Neurological diseases
  - id: MONDO:0006711
    label: Constrictive Pericarditis
  - id: MAXO:0010203
    label: Echocardiography
  - id: MAXO:0010317
    label: Chest computed tomography
  - id: HP:0003270
    label: Abdominal distension
  - id: HP:0002563
    label: Constrictive Pericarditis
  - id: HP:0001300
    label: parkinsonism
  - id: CHEBI:38161
    label: chelators
  - id: HP:0002018
    label: Nausea
  - id: HP:0002013
    label: Vomiting
  - id: HP:0001272
    label: cerebellar atrophy
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003674
    label: Onset
  - id: CHEBI:22653
    label: Asparagine
  - id: CHEBI:15891
    label: Taurine
  - id: HP:0001410
    label: hepatic dysfunction
  - id: HP:0005110
    label: atrial fibrillation
  - id: HP:0001685
    label: myocardial fibrosis
  - id: HP:0001513
    label: obesity
  - id: HP:0001392
    label: Liver disease
  - id: MONDO:0011214
    label: Progressive familial intrahepatic cholestasis type 3 (PFIC3)
  - id: HP:0001510
    label: Growth retardation
  - id: CHEBI:22587
    label: antiviral
  - id: MAXO:0000487
    label: Clinical assessments
  - id: MAXO:0000427
    label: Brain MRI
  - id: HP:0001250
    label: Seizures
  - id: MAXO:0000079
    label: genetic counseling
  - id: MAXO:0000571
    label: Brain computed tomography (CT)
  - id: CHEBI:27300
    label: Vitamin D
  - id: MONDO:0019542
    label: acute liver failure
  - id: CHEBI:30360
    label: <therapeutic plasma exchange (TPE)>
  - id: MAXO:0000900
    label: ECG
  - id: HP:0001638
    label: cardiomyopathy
  - id: HP:0003115
    label: electrocardiogram (ECG) abnormalities
  - id: HP:0012332
    label: dysautonomia
  - id: MONDO:0002691
    label: Liver cancer
  - id: HP:0001882
    label: Leukopenia
  - id: HP:0001873
    label: Thrombocytopenia
  - id: HP:0008151
    label: increased international normalized ratio
  - id: HP:0008404
    label: Dystrophic nails
  - id: HP:0011734
    label: Central adrenal insufficiency
  - id: HP:0010837
    label: Hypoceruloplasminemia
  - id: CHEBI:30512
    label: Silver
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0002040
    label: esophageal varices
